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Abstract
Objective: To fi nd out the comparison of the effect of one-
rod and two-rod levonorgestrel implants on FSH, estradiol 
levels and increase in acceptor lipid profi le after a 3-month 
evaluation in the Mother and Child Hospital of Rika Amelia 
Palembang.
Methods: This study is a phase III clinical trial, "Open" (Open 
Randomized Clinical Trial), carried out randomization by 
comparing two types of implant KB, namely levonorgestrel 
implants, one rod with two rods. This research was 
conducted at the RSIA Rika Amelia Palembang. Research 
time is 6 months from November 2018 - April 2019 or until 
the number of samples is fulfi lled.
Results: Based on the installation time, the average 
installation time using one rod LNG was 1.54 ± 0.11 minutes 
and the LNG for the two rods was 2.49 ± 0.26 minutes. 
Majority of patients having a normal blood pressure of 
89.5% in one rod LNG and 68.4% in two rod LNG. The mean 
body mass index (BMI) of respondents using LNG implants 
one rod was 24.19 ± 3.93 kg / m2 and LNG for two rods 
was 25.09 ± 6.11 kg / m2. Based on the menstrual pattern, it 
was found that 84.2% of the subjects had regular menstrual 
patterns in the one-rod LNG group, while there were 63.2 % 
of subjects who have irregular menstrual patterns. From the 
statistical test, it was found that there were no differences in 
cholesterol levels (p = 0.919), HDL (p = 0.793), LDL (p = 0.851) 
and triglycerides (p = 0.679). There were no differences in 
FSH levels between respondents using one rod and two rod 
LNG implants (p = 0.849) and also on estradiol (p = 0.099)
Conclusions: There is no difference between the use of 
one-rod and two-rod levonorgestrel implants against FSH, 
Estradiol levels and increased lipid profi le after 3 months of 
implant installation. The unpleasant effect in this study was 
the decline in HDL, but this was accompanied by a decrease 
in body weight, total cholesterol, LDL, HDL due to a decrease 
in all aspects.
Keywords: estradiol, FSH, implant contraception, 
levonorgestrel, lipid profi le, one-rod, two-rod
Abstrak
Tujuan: Untuk mengetahui perbandingan efek implan 
levonorgestrel satu-batang dan dua-batang pada FSH, 
kadar estradiol dan peningkatan profi l lipid akseptor setelah 
evaluasi 3 bulan di Rumah Sakit Ibu dan Anak Rika Amelia 
Palembang.
Metode: Penelitian ini adalah uji klinis fase III, "Open" 
(Open Randomized Clinical Trial), yang dilakukan secara 
acak dengan membandingkan dua jenis KB implan, yaitu 
levonorgestrel implan, satu batang dengan dua batang. 
Penelitian ini dilakukan di RSIA Rika Amelia Palembang. 
Waktu penelitian adalah 6 bulan dari November 2018 - April 
2019 atau hingga jumlah sampel terpenuhi.
Hasil: Berdasarkan waktu pemasangan didapatkan 
rerata waktu pemasangan yang menggunakan LNG 
satubatangadalah 1,54±0,11 menitdanpada LNG dua batang 
adalah 2,49±0,26 menit. Mayoritas pasien memiliki tekanan 
darah yang normal 89.5% pada LNG satu batang dan 68.4% 
pada LNG dua batang. Rerata indeks massa tubuh (IMT) 
responden yang menggunakan implan LNG satu batang 
sebesar 24,19 ± 3,93 kg/m2 dan LNG dua batang sebesar 
25,09 ± 6,11 kg/m2. Berdasarkan pola haid, didapatkan 
sebanyak 84,2% subjek yang memiliki pola haid teratur pada 
kelompok LNG satu batang, sedangkan terdapat sebanyak 
63,2% subjek yang memiliki pola haid tidak teratur. Dari uji 
statistik didapatkan bahwa tidak terdapat perbedaan kadar 
kolesterol (p = 0,919), HDL (p = 0,793), LDL (p = 0,851) dan 
trigliserida (p = 0,679). Tidak terdapat perbedaan kadar FSH 
antara responden yang menggunakan implan LNG satu 
batang dan dua batang (p = 0,849) dan juga pada estradiol 
(p=0.099)
Kesimpulan: Tidak terdapat perbedaan antara penggunaan 
implan levonorgestrel satu batang dan dua batang terhadap 
kadar FSH, Estradiol serta peningkatan profi l lipid setelah 3 
bulan pemasangan implan. Efek yang tidak menyenangkan 
dalam penelitian ini adalah terjadinya penurunan HDL, 
namun hal ini disertai dengan penurunan berat badan, 
kolesterol total, LDL, HDL dikarenakan terjadi penurunan 
pada seluruh aspek.
Kata kunci: dua batang, estradiol, FSH, kontrasepsi implan, 
lenovorgestrel, profi l lipid, satu  batang.
Vol 8, No 2
April 2020 Effects of Levonorgestrel Implants 92
INTRODUCTION
Implant contraception is the most important 
contraceptive method in various contraceptive 
methods available today. High effi cacy, lack 
of serious side effects, rapid reversibility, 
comfort in long-term use make implant 
method a form of contraception with a high 
level of acceptance.1Implants    are  hormonal 
contraceptives   that are implanted under 
the skin (subdermal) and used for a long 
time. This contraception contains bioactive 
progestin levonorgestrel (LNG) ingredient, 
a steroid hormone that is a derivative of 
19-nortestosterone. LNG has activities similar 
to progesterone with weak androgenic activity 
and has no estrogenic activity.1,2With the use of 
LNG implants, pregnancy is prevented through a 
combination mechanism as follows.3-5 The primary 
mechanism is producing thick cervical mucus 
that prevents sperm penetration, and inhibits 
ovulation, at approximately 50% of the menstrual 
cycle. Secondary mechanisms, which can support 
the work of the primary mechanism include 
reducing natural progesterone production by the 
ovary during the luteal phase even in cycles when 
ovulation occurs and suppresses endometrial 
growth (hypoplasia).1-6
The most common impact on the use of 
implants is a change in menstrual bleeding 
patterns. Other impacts that can arise include 
headaches, changes in mood, depression, nausea, 
changes in body weight, changes in reproductive 
hormone status, changes in carbohydrate 
metabolism and affect lipid metabolism.1,6
The LNG implant is a testosterone derivative 
that has a mineralocorticoid effect that 
affects extracellular fl uid minerals so that this 
contraception can also cause an increase in 
body weight.1,7-11Changes in lipid metabolism 
in the form of elevated triglyceride levels, total 
cholesterol, LDL and decreased HDL accompanied 
by an increase in excess body weight are 
diagnostic criteria for metabolic syndrome which 
can increase the occurrence of type II diabetes 
mellitus and cardiovascular disorders. The lipid 
profi le itself is the best predictor of metabolic 
syndrome. Therefore a study of the effect of 
Levonorgestrel implant on one rod with two rods 
on lipid profi les in acceptors is important.1,6
There was an increase in body weight in the 
use of levonorgestrel implants for 6 months 
(1.3 kg) and use of 12 months (2.4 kg). There 
was an increase in body weight (2.5 kg) during 
the 5-year use of levonorgestrel implants.10 
Estrogen is cardioprotective (protecting the 
heart) and anti-atherogenic (anti-fat formation), 
while progesterone is anti-estrogen. Changes in 
fat metabolism occur because of the hormonal 
infl uence of progesterone which causes a 
disruption in the balance of lipid profi les 
in the body. Changes in serum lipid profi le 
(triglyceride, total cholesterol, HDL and LDL) 
in long-term use of LNG are risk factors for 
atherosclerosis (accumulation of fat in the arterial 
wall) and cardiovascular.1-3,7-11Two-rod implant 
contraception, for example Jadena and Norplant 
2 rods. Jadena is a type of LNG implant consisting 
of two fl exible rods and inside each of them 
contains 75 mg of levonorgestrel. The implant 
rod is wrapped in a thin-walled silicone tube 
which at the ends is covered with medical-grade 
adhesive silastic (poly dimethyl-siloxane). His 
working period is 5 years. Whereas Norplant has 
2 soft hollow silasticrods with a length of about 
3.4 mm, and a diameter of 2.4 mm, which contains 
36 mg of levonogestrel in the form of crystals 
which are placed in the interior of the capsule 
and the working period is 3 years.4,12-14One-rod 
implant contraception, for example Implanon is 
a single implant containing etonogestrel 68 mg 
wrapped in an ethylene vinyl acetate membrane. 
His working period is 3 years. On average in the 
fi rst 6 weeks the hormone is released from 60 to 
70 mcg / day, down to 35-45mcg / day at the 
end of the fi rst year of use. The average hormone 
is released 30-40 mcg / day in the second year 
and at the end of the third year the hormone is 
released to 25-30 mcg / day.15
The advantage of a single-rod implant is the 
lower dose so that the level of levonorgestrel 
in syrodic circulation is lower, where the dose is 
expected to have a better effect than two-rod 
implants such as changes in lipid profi le or side 
effects such as changes in menstrual pattern or 
blood pressure more benefi cial to users but still 
can prevent the occurrence of pregnancy. This 
is similar to the effect of levonorgestrel in the 
vaginal ring and Mirena IUD which only contains 
52 mg of levonorgestrel released in small doses 
(20 μg / day initially and decreases to around 10 
μg / day after fi ve years).14,15
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METHODS
This study is a phase III clinical trial, "Open" 
(Open Randomized Clinical Trial), carried out 
randomization by comparing two types of 
implant KB, namely levonorgestrel implants, one 
rod with two rods. This research was conducted at 
the RSAB Rika Amelia Palembang. Research time 
is 6 months from November 2018 - April 2019 or 
until the number of samples is fulfi lled. The study 
sample was women of childbearing age and 
wanted to postpone or extend their pregnancies 
up to three years using implant contraception. 
The inclusion criteria in this study were couples 
of reproductive age 18-40 years and in good 
health, not pregnant, getting an explanation and 
understanding the objectives, risks and benefi ts 
of the study, and signing informed consent, 
subjects willing to return to the clinic, to make 
a repeat visit according to schedule and willing 
to only use implants as contraception during the 
study. The exclusion criteria in this study were 
a woman who had a history or event such as 
having experienced contraindications for long-
term hormonal contraception including vaginal 
bleeding with unclear causes, bloody discharge 
from the nipple, breast cancer or other cancers 
that are related to hormone dependence, uterine 
bleeding with unclear causes, thromboembolic 
disorders or thrombophlebitis or there is a 
history of both diseases, acute liver disease or 
liver tumour, possible pregnancy, pregnancy, 
breastfeeding have a history of idiopathic 
intracranial hypertension, history of coronary 
heart disease, cerebral vascular disease, and 
hypersensitivity to levonorgestrel or other 
components of the drug. There is a history of 
hepatitis, diabetes mellitus, depression or other 
mental disorders and epilepsy.
Blood pressure more than 180/100 mmHg. 
The study subjects were suspected of being 
diagnosed as Pelvic Infl ammatory Disease 
(PID). Severe hirsutism. Routine therapy with 
enzyme-stimulating drugs, such as barbiturates, 
phenytoin carbamazepine or rifampicin. Women 
with symptoms of amenorrhea total more 
than one year while using implants or other 
hormonal contraceptives. Have not experienced 
menstruation after giving birth. Have not had 
menstruation in the past 6 months after using 
injectable contraception or pills and are currently 
participating in other studies in the last 3 months.
Work Procedures
The fi rst step is identifi cation of the patient 
including name, age, sex, address, diagnosis, 
education, occupation and income, special 
history (obstetric and gynecological history 
(parity, fi rst day of last menstruation), history of 
previous illness, condition, blood pressure, pulse 
The patient's next procedure is the determination 
of nutritional status by measuring the weight and 
height of the pretreatment and the third month, 
height and weight measured by researchers 
assisted by paramedics, standing position and 
using microtoire. The purpose of the study was 
briefed and informed to the patients. Patients 
who agreed to participate in the study were asked 
to sign the agreement provided for this study. 
All patients who were included in this then 
get a random number, and they would get one 
of the treatment methods KB (one or two LNG 
implants) which was in accordance with the 
list of random numbers. The next step is the 
assessment of the working effect of one or two 
LNG implants in the acceptor's lipid profi le. This 
was collected by recording the acceptors’ body 
weight, menstrual patterns, total cholesterol, 
triglycerides, LDL and HDL after evaluation of 
blood serum examination from the lab. Finally, 
acceptors from both treatments were tested on 
their FSH and estradiol levels in the blood.
RESULTS
Phase III clinical trials with Open Randomized 
Clinical Trial to determine the differences in the 
effects of one-rod and two-rod levonorgestrel 
implants on FSH and estradiol levels and increase 
in acceptor lipid profi le after 3 months evaluation 
at RSAB Rika Amelia Palembang from October 
2017 to April 2018. 38 people met the inclusion 
and exclusion criteria, 19 people received one-
rod levonorgestrel implants (one rod LNG) and 
19 others received two-levonorgestrel implants 
(two-rod LNG).
General Characteristics of Research Subjects
The general characteristics of the research 
subject are shown in table 5. Based on the 
installation time, the average time of installation 
using one rod LNG implant was 1.54 ± 0.11 
minutes and the two-rod implant was 2.49 ± 
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0.26 minutes. Based on age, it was found that 
the average age of respondents using LNG one 
implant was 31.89 ± 4.97 years with the most 
age group being 20-35 years (68.4%) while the 
average age of respondents using two-rod.
LNG implants was 30.79 ± 4.43 years with the 
most age group being 20-35 years (84.2%). The 
statistical test showed that there was no differ-
Based on education, it was found that the 
majority of patients had a low level of education 
both in the one implant LNG group (57.9%) 
and two rods (63.2%). Based on statistical tests 
the results showed no difference in education 
between respondents using one rod LNG 
implants and two rods (p = 1.000). Based on 
blood pressure, the majority of patients had 
normal blood pressure of 89.5% in one rod 
LNG and 68.4% in two-rod LNG, with statistical 
tests showing no relationship between blood 
pressure and type of implant (p = 0.111). Based 
on the menstrual pattern, it was found that 
84.2% of subjects had regular menstrual patterns 
and 15.8% had irregular menstrual patterns 
in one LNG group, whereas 36.8% of subjects 
had regular menstrual patterns and 63.2 % of 
subjects who have irregular menstrual patterns. 
From the statistical test, it was found that there 
was a correlation between menstrual pattern and 
implant type (p = 0.007).
The mean Body Mass Index (BMI) of 
respondents using LNG implants in one rod 
was 24.19 ± 3.93 kg / m2 with the highest BMI 
category being normoweight (47.4%) while the 
BMI average of respondents using two-implant 
LNG was 25, 09 ± 6.11 kg / m2 with the highest 
ence in age (p = 0.474) or age group (p = 0.447) 
between respondents who used LNG implants in 
one rod and two rods. In this study, the majority 
of parity respondents both using one rod of LNG 
implants (57.9%) and two rods (68.4%) were ≥ 3. 
With statistical tests it was found that there was 
no difference in parity between respondents us-
ing one LNG implant and two rods (p = 0.737).
Table 1. General Characteristics of Research Subjects
aIndependent T Test, p = 0.05, bUji Fisher Exact, p = 0.05, cChi Square test, p =0.05, dMann Whitney 
test, p =0.05, ePearson Chi Square test, p =0.05
Variabel
Installation Time
Mean± SD
Median (Min-Max)
Age
Mean ± SD
Median (Min-Max)
Age, n(%)
20-35  
> 35 
Parity, n(%)
0
1-2
Education, n(%)
Low
High
Blood Pressure
Normal
Hypertension
Menstruation Cycle
Regular
Irregular
Body Mass Index
Mean ± SD
Median (Min-Max)
Body Mass Index, n(%)
Underweight
Normoweight
Overweight
Obese
One Rod
1.54 ± 0.11
1.52 (1.48 - 2.00)
31.89 ± 4.97
31 (23 - 39)
13 (68.4)
6 (31.6)
8 (42.1)
11 (57.9)
11 (57.9)
8 (42.1)
17 (89.5)
2 (10.5)
16 (84.2)
3 (15.8)
24.19 ± 3.93
23.2 (19.3 - 35.9)
0 (0)
9 (47.4)
5 (26.3)
5 (26.3)
Two Rod
2.49 ± 0.26
2.53 (1.49 - 3.00)
30.79 ± 4.43
32 (21-36)
16 (84.2)
3 (15.8)
6 (31.6)
13 (68.4)
12 (63.2)
7 (36.8)
13 (68.4)
6 (31.6)
7 (36.8)
12 (63.2)
25.09 ± 6.11
23.1 (17.8 – 39.3)
1 (5.3)
8 (42.1)
3 (15.8)
7 (36.8)
0.000d
0.474a
0.447b
0.737c
1.000c
0.111e
0.007b
0.965d
0.595e
Levonorgestrel P-value
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BMI category normoweight (42.1%). With 
statistical tests, it was found that there was no 
difference in BMI (p = 0.965) or BMI category (p 
= 0.595) among respondents who used one-rod 
implant and two LNG implants.
Likewise with the levels of FSH and estradiol 
before treatment, it was found that there were no 
differences in FSH levels (p = 0.673) or estradiol 
(p = 0.215) between respondents using one-rod 
implant and two LNG implants.
Difference in Effectiveness of Use of One-Rod 
and Two-LNG LNG Implants on Lipid Profi les
The study found a signifi cant reduction in 
cholesterol after 3 months both after the use of 
one rod of LNG (p = 0.000) and two rods (p = 
0,000), there was a signifi cant decrease in HDL 
after 3 months both after the use of one rod 
LNG (p = 0.000) or two (p = 0.000), there was a 
signifi cant reduction in LDL after 3 months both 
after the use of one rod LNG (p = 0.040) and two 
rods (p = 0.000), and a signifi cant increase in 
triglycerides after 3 months after the use of one 
rod LNG (p = 0.687) or two rods (p = 0.543).
In addition, it was found that there were no 
differences in cholesterol levels (p = 0.919), HDL 
(p = 0.793), LDL (p = 0.851) and triglycerides (p = 
0.679) among respondents using one rod implant 
and two LNG implants.
aPaired T Test, p =0,05, bUji Wilcoxon, p =0.05, cMann Whitney test, p =0.05, dIndependent T Test, p =0.05
Laboratory Characteristics of 
Research Subjects
The laboratory characteristics of the research 
subject can be seen in table 6. Based on 
statistical tests there were no differences in lipid 
profi les before treatment of both cholesterol (p 
= 0.260), HDL (p = 0.989), LDL (p = 0.791) and 
triglycerides (p = 0.447) between the two group 
of respondents.
Table 2. Laboratory Characteristics of Research Subjects
Table 3. Effectiveness of the Use of One-Rod and Two-LNG LNG Implants on Lipid Profi les
Variable One Rod Two Rod
aIndependent T Test, p = 0,05, bMann Whitney test, p =0,05
Variabel
Total cholesterol
Mean ± SD
Median (Min-Max)
HDL
Mean ± SD
Median (Min-Max)
LDL
Mean ± SD
Median (Min-Max)
Triglycerides
Mean ± SD
Median (Min-Max)
FSH
Mean ± SD
Median (Min-Max)
Estradiol
Mean ± SD
Median (Min-Max)
Cholesterol
HDL
LDL
Triglycerides
before
234.4 ± 30.9
66.1 ± 10.6
103.5 ± 20.9
94.5 ± 53.9
after
155.9 ± 30.9
45.9 ± 8.8
92.9 ± 23.7
946 ± 34.2
p-value
0.000a
0.000a
0.040a
0.687b
p-value
0.000b
0.000b
0.000a
0.543a
p-value
0.919c
0.793c
0.851d
0.679d
before
246.7 ± 30.9
66.0 ± 13.9
105.3 ± 19.4
95.4 ± 45.5
after
159.3 ± 32.9
47.4 ± 12.5
94.2 ± 16.6
99.3 ± 35.9
One Rod
234.4± 30.9
235.4 (191.1-308.9)
66.10 ± 10.63
67.3 (44.9 – 88.4)
103.5 ± 20.88
98.9 (68.1 – 150.4)
31.89 ± 4.97
31 (23-39)
4.93 ± 2.63
5.11 (0.81 – 12.0)
33.52 ± 37.77
18.91 (13.42 – 163.9)
Two Rod
246.7 ± 35.00
240.5 (196.1 – 326.2)
66.05 ± 13.94
65,7 (44.1 – 94.7)
105.28 ± 19.38
101.1 (75.1 – 137.6)
30.79 ± 4.43
32 (21-36)
5.28 ± 3.45
4.94 (0.87 – 15.1)
19.74 ± 9.99
17.7 (10.18–49.84)
0.260a
0.989a
0.791a
0.737b
0.673a
0.215b
Levonorgestrel P-value
Vol 8, No 2
April 2020 Effects of Levonorgestrel Implants 96
The difference in the Effectiveness of Using 
One-Rod LNG Implants and Two-Rod LNG 
LNG Implants on FSH and Estradiol
The results showed that there was no 
signifi cant decrease in FSH levels before and 3 
months after using one rod of LNG (p = 0.063), 
but it was found that there was no signifi cant 
decrease in estradiol levels before and 3 months 
after using one rod of LNG (p = 0.059).
In addition, it was found that there was no 
signifi cant decrease in FSH levels before and 3 
months after using two rods of LNG (p = 0.117), 
other than that there was a signifi cant decrease 
in estradiol levels before and 3 months after the 
use of LNG in two rods (p = 0.295). In this study, 
it was also found that there were no signifi cant 
differences in FSH levels between respondents 
using one-rod and two-rod LNG implants (p = 
0.849), respondents who used two-rod LNG had 
higher FSH levels than respondents using one-
rod LNG but not meaningful. In addition, it was 
found that there were no signifi cant differences 
in estradiol levels between respondents using 
one-rod and two-rod LNG implants (p = 0.099), 
respondents who used two-rod LNG had lower 
estradiol levels than respondents using one-rod 
LNG but were not signifi cant.
DISCUSSION
Contraception is efforts made to prevent 
pregnancy, both temporary and permanent. 
Implants are hormonal contraceptives that are 
implanted under the skin (subdermal) and used 
for a long time. This contraception contains 
bioactive progestin levonorgestrel (LNG) 
ingredient, a steroid hormone that is a derivative 
of 19-nortestosterone. LNG has activities similar 
to progesterone with weak androgenic activity 
and has no estrogenic activity.1,2
Levonorgestrel is a progestin hormone which 
is a derivative of 19-nortetosterone. As an active 
contraceptive implant substance, levonorgestrel 
is a steroid hormone with strong progesterone 
activity and weak androgen activity, the chemical 
formula of the hormone. There are two types 
of Levonorgestrel implant contraceptives, one 
LNG rod and two rods. In this study, several 
samples were taken at different times. A total of 
21 samples were implanted with implants on 15 
December 2018 and 17 samples were installed 
on January 5, 2019. Sampling was carried out at 
the RSAB Rika Amelia Palembang. There were 21 
samples that met the research criteria and were 
willing to take part in the study from 50 samples. 
The second sample was taken in a different place 
and 17 samples that met the study criteria were 
obtained.
In this study, it was found that the average 
installation time required for one rod LNG was 
1.54 ± 0.11 minutes and for LNG two rods was 
2.49 ± 0.26 minutes. From the data above we can 
see that the installation of one rod of LNG is faster 
than with two  LNG. If viewed from the cost, LNG 
one rod only requires local anesthetic in the form 
of one ampoule lidocaine, while LNG for two rods 
requires two ampoules of lidocaine. There are no 
other differences either from the use of alcohol 
cotton, plaster, or syringes between the one rod 
LNG group and the two rod LNG. From this study 
it was also found that there was no difference 
between changes in blood pressure in the LNG 
group of one rod and LNG in two rod.
Implanted KB acceptors in the study were 
approximately 31 years old with the majority 
of the age categories 20-35 years (76.3%). The 
results of showed the percentage of implant KB 
acceptors aged 20-35 years was 54.8%. Study in 
2017 showed an average age of patients using 
implants of approximately 34.3 years. The type 
of contraception used should be adjusted to 
the stage of reproduction.16Age 20-35 years 
is a period of reproductive life so the choice 
of contraception used is oral contraception or 
implant.
The majority of implantable KB acceptors 
parity ≥ 3 (63.2%) with a mean parity of 3.07 
aPaired T Test, p =0.05, bWilcoxon test, p =0.05, cMann Whitney test, p =0.05
Table 4. Effectiveness of the Use of the One-Rod and Two-Rod LNG LNG Implants against FSH and Estradiol
Variable LNG One-Rod LNG Two-Rod p-value
FSH
Estradiol
before
4.93 ± 2.63
33.52 ± 37.77
after
4.15 ± 1.96
21.86 ± 12.07
p-value
0.063a
0.059b
p-value
0.117b
0.295b
0.849c
0.099c
before
5.28 ± 3.45
19.74 ± 9.99
after
4.43 ± 2.14
18.32 ± 10.79
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± 1.02. This result is not much different from 
the research in 2017 where the implant parity 
acceptor implies a mean of 3.0 ± 2.0. The more 
often a woman gives birth to a child, the more 
risks she will have in childbirth. This means that 
the number of children will greatly infl uence the 
choice of mothers to choose contraception.16 
In couples with a small number of children (3 
children or less) there is a tendency to use low-
effectiveness contraceptives, namely pills and 
condoms, whereas if the child is felt quite a lot, a 
higher effectiveness contraceptive device will be 
used such as implants.
Based on blood pressure, the majority of 
patients had a normal blood pressure of 89.5% 
in one rod LNG and 68.4% in two rod LNG, 
with statistical tests showing that there was no 
correlation between blood pressure and implant 
type (p = 0.111). Based on the menstrual pattern, 
it was found that 84.2% of subjects had regular 
menstrual patterns and 15.8% had irregular 
menstrual patterns in one LNG group, whereas 
36.8% of subjects had regular menstrual patterns 
and 63.2 % of subjects who have irregular 
menstrual patterns. From the statistical test, it 
was found that there was a correlation between 
menstrual pattern and implant type (p = 0.007).
In this study, it was found that LNG was 
associated with changes in menstrual patterns, 
both the use of one rod of LNG and two rods. 
Descriptively, there were 63.2% of subjects who 
had irregular menstrual patterns. The possibility 
of side effects that can occur is irregular 
menstruation. This is because LNG does not 
contain estrogen, which causes disruption of the 
menstrual cycle. Most women can know some 
variations in menstrual patterns. The use of 
Jadelle contraception has almost the same side 
effects as the use of Norplant contraception in the 
form of irregular menstrual bleeding, prolonged 
bleeding or spots (longer than a woman usually 
experiences), heavy bleeding, bleeding or spots 
between periods, no bleeding at all for several 
months, or a combination of these patterns. 
Hypertension can occur in 1.0% - 9.9% of women 
who use LNG contraception. However, this study 
did not show a signifi cant relationship between 
hypertension and use of LNG contraception.6,17,18
In the distribution of subjects according to 
implant type and BMI, there was a mean BMI 
in one rod of LNG before and after implant 
placement at 24.16 ± 3.97 kg / m2 and 23.79 ± 
4.09 kg / m2. While the mean BMI for LNG in the 
two rods before and after implant placement was 
25.21 ± 6.01 kg / m2 and 26.21 ± 6.60 kg / m2. 
Descriptively, LNG of two rods showed an increase 
in body weight of 1 kg / m2 where one rod of 
LNG decreased BMI by 0.37 kg / m2. This result is 
different from the results of a study that there was 
a weight loss of 0.33% in the use of 2 rod LNG. 
Although there was an increase in BMI on 2-rod 
LNG, did not fi nd any signifi cant differences. The 
results of this study on IMT cannot be concluded, 
because the increase in BMI was infl uenced by 
dietary patterns not assessed in this study.6,19
In the distribution of subjects according to 
implant type and cholesterol, there was a mean 
cholesterol in the type of LNG 1 rod before and 
after implant placement was 234.42 ± 30.99 
mg / dL and 155.86 ± 30.94 mg / dL. While the 
mean cholesterol in 2 rod LNG before and after 
implant placement was 246.68 ± 35.01 mg / dL 
and 159.32 ± 32.85 mg / dL. In this study there 
was a signifi cant reduction in cholesterol levels 
in the group that received one rod and two LNG 
but there was no difference between the two 
groups. Descriptively, one rod LNG showed a 
decrease of 78.56 mg / dL, while LNG for two bars 
showed a decrease of 87.36 mg / dL. Two more 
LNG trunks show a larger decrease compared 
to one rod LNG. Research in 2017 showed an 
increase in total cholesterol levels after 6 and 
12 months of implant placement, but decreased 
after 24 months. The difference obtained is 
probably because in this study the follow-up was 
carried out for 3 months. There was a decrease in 
cholesterol after LNG use after 3 months with a 
p value of <0.05 and a mean cholesterol value of 
141.17 ± 14.67 mg / dL.18,20
In the distribution of subjects according to 
implant type and HDL in the blood, there was a 
mean HDL in LNG rods before and after implant 
placement was 66.10 ± 10.62 mg / dL and 45.94 
± 8.79 mg / dL. While the mean HDL in 2-rod 
LNG before and after implant placement was 
66.05 ± 13.95 mg / dL and 47.40 ± 12.53 mg/dL. 
Descriptively, one rod of LNG showed a decrease 
in HDL of 20.16 mg / dL, while LNG of two rods 
showed a decrease in HDL of 18.65 mg / dL. One 
rod LNG showed more levels of HDL decrease. In 
the distribution of subjects according to implant 
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type and LDL in the blood, there was a mean LDL 
in implant type 1 rod before and after implant 
placement was 103.54 ± 20.88 mg / dL and 92.92 
± 23.68 mg / dL. While the mean LDL in the 2-rod 
implant type before and after implant placement 
was 105.28 ± 19.38 mg / dL and 94.18 ± 16.56 
mg / dL. Descriptively LNG one rod showed a 
decrease of 10.62 mg / dL, while LNG for two rods 
showed a decrease of 11.1 mg / dL. Two more 
LNG LNG showed a decrease in LDL compared to 
one rod LNG.
There was a signifi cant reduction in HDL and 
LDL in the group that received one rod and two 
LNG LNG but there was no difference between 
the two groups. In 2017 LDL reduction was found 
after 6, 12 and 24 months but there was an 
increase in HDL levels, this is different from the 
results of this study. Dash's research found that 
there was a signifi cant decrease in HDL after the 
installation of 2-rod LNG within 3 months with 
a value of p = 0.02 and an average HDL level of 
40.00 ± 8.65 and a signifi cant decrease in LDL 
after installation of 2-rod LNG within 3 months 
with p = 0.05 and the mean LDL level was 92.33 
± 11.60.18,20
In the distribution of subjects according to 
implant and triglyceride types, there were mean 
triglycerides in LNG 1 rod before and after implant 
placement were 94.46 ± 53.87 mg / dL and 94.58 
± 34.23 mg / dL. While the mean of triglycerides 
in 2 rod LNG before and after implant placement 
was 95.38 ± 45.48 mg / dL and 99.33 ± 35.93 
mg / dL. Descriptively, one rod LNG showed 
an increase of 0.12 mg / dL, while LNG for two 
bars showed an increase of 3.95 mg / dL. LNG 
of two rods showed an increase in triglycerides 
compared to one rod LNG. In this study there 
was an increase in triglyceride levels both in the 
group that received one rod and two LNG LNG 
but the increase that occurred was not statistically 
signifi cant. The increase in the LNG group of two 
rods was greater than that in the one-rod LNG 
group but was not signifi cant. These results are in 
line. Study in which triglyceride levels increased 
after administration of implants for 6, 12 and 
24 months. There was a signifi cant decrease in 
triglycerides after the installation of 2-rod LNG 
within 3 months with a p value of <0.01 and the 
average triglyceride level was 76.65 ± 19.95.18,20
Changes in fat metabolism in hormonal 
contraceptive use are caused by estrogen and 
progesterone, each of which has a different effect. 
Estrogen is cardioprotective (protecting the heart) 
and antiatherogenic (anti-fat formation), while 
progesterone is anti-estrogen. The use of a single 
estrogen will reduce the activity of the lipoprotein 
lipase enzyme, increase HDL cholesterol levels 
and reduce LDL cholesterol levels. The effect of 
progesterone is precisely inversely proportional 
to the effect of estrogen, and this effect depends 
on the potential of the androgen. The stronger 
the androgen potential, the greater the adverse 
effect on fat metabolism.3,7-9,11
The mineral corticoid effects of LNG implants 
can cause weight gain. Weight gain is one of the 
causes of an increase in triglyceride levels and a 
decrease in HDL levels that occurred in this study, 
but it is different with decreasing total cholesterol 
and LDL levels.
Some of the results of this study are different 
from previous studies. Research in Ghana shows 
that hormonal contraception can increase BMI, 
diastolic blood pressure, total cholesterol levels, 
LDL cholesterol levels and reduce HDL cholesterol 
levels in the blood. Where this change is a 
potential risk factor for developing cardiovascular 
disease.8Research at the Benin Teaching Hospital, 
Nigeria showed that Implanon had an effect on 
lipid metabolism, there was a signifi cant decrease 
in HDL and an increase in LDL levels in the 6th 
and 12th months.10The differences that occur in 
this study are likely because the patient's follow-
up time is too short.
In the distribution of subjects according to 
implant type and FSH, there was a mean FSH 
for implant types 1 rod before and after implant 
placement was 4.93 ± 2.63 and 4.15 ± 1.96. While 
the mean FSH for 2-rod implant types before and 
after implant placement was 5.29 ± 3.46 and 
4.44 ± 2.14. Descriptively, one rod LNG showed 
a decrease in FSH of 0.78, while LNG of two rods 
showed a decrease in FSH of 0.85. Two more 
LNG LNG showed a decrease in FSH compared 
to one rod LNG. From the results of the analysis, 
it was found that there was a signifi cant decrease 
in FSH levels after the installation of one rod 
LNG implant or two rods for 3 months. In the 
distribution of subjects according to implant and 
estradiol types, there were Estradiol meanings on 
the type of implant 1 rod before and after implant 
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placement 33.52 ± 37.77 and 21.86 ± 12.07. 
While the Estradiol mean on the 2-rod implant 
type before and after implant placement was 
19.74 ± 9.99 and 18.32 ± 10.79. Descriptively, one 
rod LNG showed a reduction in Estradiol of 11.66 
while the LNG of two rods showed a decrease 
in Estradiol of 1.42. There is a greater decrease 
in one-rod LNG with Estradiol levels. From the 
results of the analysis it was also found that there 
was no signifi cant decrease in estradiol levels 
after the installation of one rod LNG implant or 
two rods for 3 months.
In two-rod implants that are effective for 5 
years, levonorgestrel will be released as much as 
50-80 μg / day for the fi rst year of installation 
and release the following year until the 5th year 
of use is 30-35 μg / day.4,5Whereas on one rod 
implant the average in the fi rst 6 weeks of the 
hormone is released from 60 to 70 mcg / day, 
down to 35-45mcg / day at the end of the fi rst 
year of use. The main working mechanism of 
LNG is to inhibit ovulation in about 50% of the 
menstrual cycle. A small amount of LNG released 
from the implant continuously will work in the 
hypothalamus and anterior pituitary gland. 
Furthermore, there is a decrease in FSH secretion 
(follicle stimulating hormone) and LH (lutenizing 
hormone). LNG will inhibit or reduce LH surge in 
the middle of the cycle. The anterior pituitary sex 
hormone, Follicle Stimulating Hormone (FSH) is 
secreted in response to hypothalamic hormones. 
FSH functions to stimulate the ovaries to produce 
steroids. Steroid hormones have a large effect on 
the menstrual cycle, where estrogen is produced 
in the follicular and progesterone phases during 
the luteal phase of the ovary. Estrogen has a strong 
effect on inhibiting LH and FSH production. The 
effect of inhibiting estrogen will increase if there 
is progesterone, although the progesterone itself 
has only a small effect.16-18,20,21
Whereas on one rod implant the average in 
the fi rst 6 weeks of the hormone is released from 
60 to 70 mcg / day, down to 35-45mcg / day at 
the end of the fi rst year of use. The main working 
mechanism of LNG is to inhibit ovulation in about 
50% of the menstrual cycle. A small amount of LNG 
released from the implant continuously will work 
in the hypothalamus and anterior pituitary gland. 
Furthermore, there is a decrease in FSH secretion 
(follicle-stimulating hormone) and LH (luteinizing 
hormone). LNG will inhibit or reduce LH surge in 
the middle of the cycle. The anterior pituitary sex 
hormone, follicle-stimulating hormone (FSH) is 
secreted in response to hypothalamic hormones. 
FSH functions to stimulate the ovaries to produce 
steroids. Steroid hormones have a large effect on 
the menstrual cycle, where estrogen is produced 
in the follicular and progesterone phases during 
the luteal phase of the ovary. Estrogen has a strong 
effect on inhibiting LH and FSH production. The 
effect of inhibiting estrogen will increase if there 
is progesterone, although the progesterone itself 
has only a small effect.
CONCLUSION
There is no difference between the use of one-
stem and two-stem levonorgestrel implants 
against FSH, Estradiol levels and increased lipid 
profi le after 3 months of implant installation 
with a value of p = 0.673, p = 0.215, p = 0.260, 
p = 0.989, p = 0.791. The unpleasant effect in 
this study was the decline in HDL, but this was 
accompanied by a decrease in body weight, total 
cholesterol, LDL, HDL due to a decrease in all 
aspects.
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